| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Semen Analysis | 46 | 2023 | 204 | 9.550 |
Why?
|
| Pesticide Residues | 16 | 2023 | 95 | 6.910 |
Why?
|
| Infertility | 32 | 2024 | 655 | 6.610 |
Why?
|
| Infertility, Female | 38 | 2023 | 784 | 5.610 |
Why?
|
| Hypertension, Pregnancy-Induced | 11 | 2023 | 485 | 5.240 |
Why?
|
| Fertility | 30 | 2023 | 770 | 5.080 |
Why?
|
| Diabetes, Gestational | 43 | 2024 | 1184 | 4.850 |
Why?
|
| Sperm Count | 25 | 2023 | 216 | 4.440 |
Why?
|
| Reproductive Techniques, Assisted | 29 | 2022 | 482 | 4.030 |
Why?
|
| Diet | 68 | 2023 | 7923 | 3.710 |
Why?
|
| Menstrual Cycle | 10 | 2022 | 551 | 3.590 |
Why?
|
| Abortion, Spontaneous | 12 | 2023 | 542 | 3.560 |
Why?
|
| Spermatozoa | 20 | 2020 | 625 | 3.190 |
Why?
|
| Pregnancy | 166 | 2024 | 29087 | 3.180 |
Why?
|
| Semen | 16 | 2023 | 316 | 3.110 |
Why?
|
| Vegetables | 19 | 2023 | 1179 | 3.060 |
Why?
|
| Nurses | 24 | 2023 | 2459 | 3.020 |
Why?
|
| Fruit | 19 | 2023 | 1139 | 3.010 |
Why?
|
| Infertility, Male | 17 | 2020 | 407 | 2.980 |
Why?
|
| Pre-Eclampsia | 9 | 2023 | 1196 | 2.940 |
Why?
|
| Dietary Fats | 19 | 2022 | 2017 | 2.900 |
Why?
|
| Preconception Care | 10 | 2021 | 134 | 2.570 |
Why?
|
| Prospective Studies | 179 | 2024 | 53187 | 2.550 |
Why?
|
| Trans Fatty Acids | 7 | 2022 | 153 | 2.500 |
Why?
|
| Pesticides | 11 | 2023 | 287 | 2.430 |
Why?
|
| Body Mass Index | 63 | 2023 | 12695 | 2.420 |
Why?
|
| Menstruation Disturbances | 5 | 2021 | 148 | 2.400 |
Why?
|
| Fertilization in Vitro | 24 | 2023 | 1284 | 2.380 |
Why?
|
| Ovulation | 8 | 2016 | 189 | 2.140 |
Why?
|
| Sperm Motility | 18 | 2023 | 253 | 2.130 |
Why?
|
| Dairy Products | 12 | 2019 | 498 | 2.120 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 10 | 2020 | 378 | 2.100 |
Why?
|
| Cesarean Section | 7 | 2021 | 1363 | 1.960 |
Why?
|
| Overweight | 18 | 2022 | 2366 | 1.950 |
Why?
|
| Diet Surveys | 20 | 2021 | 1172 | 1.920 |
Why?
|
| Soy Foods | 4 | 2016 | 48 | 1.880 |
Why?
|
| Live Birth | 18 | 2021 | 512 | 1.860 |
Why?
|
| Feeding Behavior | 22 | 2022 | 3187 | 1.790 |
Why?
|
| Pregnancy Outcome | 24 | 2023 | 2795 | 1.730 |
Why?
|
| Diabetes Mellitus, Type 2 | 28 | 2024 | 11695 | 1.670 |
Why?
|
| Adult | 222 | 2023 | 213712 | 1.580 |
Why?
|
| Reproduction | 9 | 2023 | 668 | 1.580 |
Why?
|
| Seafood | 7 | 2018 | 384 | 1.570 |
Why?
|
| Female | 289 | 2024 | 379592 | 1.570 |
Why?
|
| Menarche | 9 | 2023 | 513 | 1.540 |
Why?
|
| Caffeine | 7 | 2018 | 699 | 1.540 |
Why?
|
| Occupational Exposure | 11 | 2021 | 1794 | 1.470 |
Why?
|
| Pregnancy Rate | 20 | 2022 | 643 | 1.460 |
Why?
|
| Folic Acid | 12 | 2021 | 1300 | 1.450 |
Why?
|
| Meat | 6 | 2019 | 595 | 1.430 |
Why?
|
| Environmental Pollutants | 11 | 2023 | 1180 | 1.420 |
Why?
|
| Obesity | 32 | 2024 | 12705 | 1.410 |
Why?
|
| Agaricales | 2 | 2019 | 29 | 1.390 |
Why?
|
| Risk Factors | 115 | 2024 | 72145 | 1.380 |
Why?
|
| Humans | 374 | 2024 | 742088 | 1.370 |
Why?
|
| Fatty Acids | 9 | 2023 | 1806 | 1.360 |
Why?
|
| Dietary Supplements | 22 | 2023 | 3294 | 1.360 |
Why?
|
| Life Style | 20 | 2023 | 3824 | 1.330 |
Why?
|
| Sweetening Agents | 6 | 2022 | 296 | 1.320 |
Why?
|
| Premature Birth | 4 | 2023 | 1713 | 1.240 |
Why?
|
| Fatty Acids, Omega-3 | 9 | 2022 | 1341 | 1.220 |
Why?
|
| Adiposity | 8 | 2023 | 1806 | 1.220 |
Why?
|
| Follicle Stimulating Hormone | 11 | 2023 | 738 | 1.210 |
Why?
|
| Anovulation | 6 | 2016 | 58 | 1.170 |
Why?
|
| Environmental Exposure | 18 | 2023 | 4231 | 1.170 |
Why?
|
| Cohort Studies | 64 | 2024 | 40450 | 1.170 |
Why?
|
| Phenols | 8 | 2023 | 501 | 1.160 |
Why?
|
| Delivery, Obstetric | 4 | 2021 | 904 | 1.140 |
Why?
|
| Endometriosis | 12 | 2023 | 834 | 1.130 |
Why?
|
| Phthalic Acids | 8 | 2023 | 436 | 1.090 |
Why?
|
| Eating | 7 | 2019 | 1535 | 1.090 |
Why?
|
| Coffee | 4 | 2022 | 578 | 1.080 |
Why?
|
| Sexual Behavior | 8 | 2021 | 2050 | 1.060 |
Why?
|
| Disinfectants | 3 | 2021 | 116 | 1.020 |
Why?
|
| Weight Gain | 9 | 2022 | 2282 | 1.000 |
Why?
|
| Carbonated Beverages | 5 | 2022 | 214 | 0.990 |
Why?
|
| Fertilization | 2 | 2023 | 195 | 0.990 |
Why?
|
| Cannabis | 3 | 2023 | 432 | 0.980 |
Why?
|
| Young Adult | 77 | 2023 | 56350 | 0.970 |
Why?
|
| Adolescent | 79 | 2023 | 85649 | 0.960 |
Why?
|
| Male | 159 | 2023 | 349538 | 0.950 |
Why?
|
| Prostatic Neoplasms | 14 | 2019 | 11039 | 0.950 |
Why?
|
| Waist Circumference | 5 | 2022 | 917 | 0.940 |
Why?
|
| Meat Products | 2 | 2014 | 99 | 0.940 |
Why?
|
| Fluorocarbons | 3 | 2023 | 452 | 0.920 |
Why?
|
| Diet, Mediterranean | 11 | 2022 | 696 | 0.920 |
Why?
|
| Ovarian Follicle | 9 | 2023 | 247 | 0.910 |
Why?
|
| Cardiovascular Diseases | 14 | 2024 | 15108 | 0.910 |
Why?
|
| Fatty Acids, Monounsaturated | 4 | 2022 | 194 | 0.900 |
Why?
|
| Endocrine Disruptors | 2 | 2023 | 237 | 0.890 |
Why?
|
| Menopause | 5 | 2023 | 1621 | 0.890 |
Why?
|
| Vitamins | 9 | 2023 | 1608 | 0.880 |
Why?
|
| Nutrition Assessment | 7 | 2015 | 723 | 0.860 |
Why?
|
| Sperm Injections, Intracytoplasmic | 7 | 2021 | 160 | 0.860 |
Why?
|
| Gonadal Steroid Hormones | 5 | 2018 | 711 | 0.850 |
Why?
|
| Food Contamination | 2 | 2023 | 189 | 0.840 |
Why?
|
| Marijuana Smoking | 3 | 2019 | 252 | 0.810 |
Why?
|
| Pregnancy Complications | 8 | 2021 | 2861 | 0.800 |
Why?
|
| Stillbirth | 2 | 2014 | 346 | 0.790 |
Why?
|
| Birth Weight | 8 | 2023 | 2068 | 0.790 |
Why?
|
| beta Carotene | 2 | 2019 | 527 | 0.790 |
Why?
|
| Denmark | 12 | 2021 | 736 | 0.780 |
Why?
|
| Menopause, Premature | 1 | 2022 | 132 | 0.780 |
Why?
|
| Anti-Mullerian Hormone | 7 | 2023 | 399 | 0.760 |
Why?
|
| Testis | 3 | 2020 | 800 | 0.760 |
Why?
|
| Intention | 1 | 2023 | 338 | 0.740 |
Why?
|
| Incidence | 32 | 2023 | 20928 | 0.720 |
Why?
|
| Maternal Mortality | 1 | 2023 | 310 | 0.720 |
Why?
|
| Fathers | 3 | 2021 | 357 | 0.720 |
Why?
|
| Prenatal Exposure Delayed Effects | 8 | 2022 | 2407 | 0.720 |
Why?
|
| Nutritional Status | 6 | 2021 | 1606 | 0.710 |
Why?
|
| Child Abuse | 3 | 2023 | 1030 | 0.710 |
Why?
|
| Diethylhexyl Phthalate | 5 | 2023 | 81 | 0.690 |
Why?
|
| Benzhydryl Compounds | 5 | 2022 | 840 | 0.690 |
Why?
|
| Exercise | 12 | 2021 | 5611 | 0.690 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2020 | 123 | 0.690 |
Why?
|
| Beverages | 7 | 2022 | 820 | 0.680 |
Why?
|
| Homosexuality, Female | 5 | 2021 | 157 | 0.670 |
Why?
|
| Fishes | 6 | 2018 | 569 | 0.670 |
Why?
|
| Sexual Maturation | 2 | 2019 | 265 | 0.670 |
Why?
|
| Paternal Exposure | 2 | 2019 | 89 | 0.670 |
Why?
|
| Body Weight | 14 | 2022 | 4664 | 0.670 |
Why?
|
| Reproductive History | 2 | 2023 | 209 | 0.660 |
Why?
|
| Lifting | 2 | 2017 | 55 | 0.660 |
Why?
|
| Longitudinal Studies | 23 | 2022 | 13921 | 0.640 |
Why?
|
| Neoplasms | 13 | 2023 | 21596 | 0.630 |
Why?
|
| Clothing | 1 | 2018 | 92 | 0.630 |
Why?
|
| Occupational Diseases | 4 | 2019 | 1472 | 0.620 |
Why?
|
| United States | 62 | 2024 | 69693 | 0.620 |
Why?
|
| Parity | 8 | 2023 | 929 | 0.610 |
Why?
|
| Proportional Hazards Models | 20 | 2023 | 12344 | 0.610 |
Why?
|
| Pyrethrins | 1 | 2017 | 47 | 0.610 |
Why?
|
| Mothers | 10 | 2023 | 2163 | 0.610 |
Why?
|
| Self Report | 15 | 2022 | 3548 | 0.600 |
Why?
|
| Coitus | 1 | 2018 | 133 | 0.600 |
Why?
|
| Pregnancy, Ectopic | 1 | 2018 | 141 | 0.600 |
Why?
|
| Birth Intervals | 1 | 2017 | 51 | 0.590 |
Why?
|
| Work Schedule Tolerance | 3 | 2017 | 565 | 0.590 |
Why?
|
| Heterosexuality | 6 | 2021 | 271 | 0.590 |
Why?
|
| Middle Aged | 82 | 2024 | 213127 | 0.580 |
Why?
|
| Longevity | 4 | 2024 | 1069 | 0.580 |
Why?
|
| Dietary Proteins | 6 | 2018 | 963 | 0.580 |
Why?
|
| Phospholipids | 1 | 2020 | 781 | 0.570 |
Why?
|
| Antioxidants | 5 | 2019 | 1659 | 0.570 |
Why?
|
| Body Composition | 4 | 2022 | 2400 | 0.570 |
Why?
|
| Erectile Dysfunction | 1 | 2020 | 459 | 0.570 |
Why?
|
| Cross-Sectional Studies | 32 | 2023 | 24913 | 0.570 |
Why?
|
| Child | 51 | 2024 | 77478 | 0.560 |
Why?
|
| Fetal Development | 2 | 2021 | 767 | 0.560 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2020 | 501 | 0.550 |
Why?
|
| Follow-Up Studies | 38 | 2022 | 39004 | 0.550 |
Why?
|
| Ascorbic Acid | 1 | 2019 | 647 | 0.550 |
Why?
|
| Weight Loss | 6 | 2023 | 2604 | 0.550 |
Why?
|
| Sodium, Dietary | 1 | 2020 | 418 | 0.550 |
Why?
|
| Vitamin E | 1 | 2020 | 869 | 0.540 |
Why?
|
| Dietary Carbohydrates | 5 | 2022 | 904 | 0.540 |
Why?
|
| Alcohol Drinking | 8 | 2021 | 3957 | 0.540 |
Why?
|
| Vitamin B Complex | 3 | 2019 | 288 | 0.530 |
Why?
|
| Hypercholesterolemia | 1 | 2022 | 1149 | 0.530 |
Why?
|
| Cause of Death | 3 | 2021 | 3571 | 0.530 |
Why?
|
| Air Pollutants | 8 | 2023 | 2814 | 0.520 |
Why?
|
| Diet Records | 4 | 2020 | 425 | 0.510 |
Why?
|
| Linear Models | 14 | 2019 | 5948 | 0.510 |
Why?
|
| Fetal Mortality | 1 | 2014 | 19 | 0.510 |
Why?
|
| Genital Diseases, Female | 1 | 2016 | 197 | 0.510 |
Why?
|
| Television | 4 | 2014 | 409 | 0.510 |
Why?
|
| Self-Assessment | 1 | 2017 | 390 | 0.500 |
Why?
|
| Infant, Newborn | 19 | 2023 | 25575 | 0.500 |
Why?
|
| Functional Food | 1 | 2014 | 19 | 0.490 |
Why?
|
| Sexual Partners | 2 | 2019 | 730 | 0.490 |
Why?
|
| Air Pollution | 8 | 2023 | 2284 | 0.490 |
Why?
|
| Work | 1 | 2015 | 191 | 0.480 |
Why?
|
| Diet, Vegetarian | 1 | 2016 | 173 | 0.480 |
Why?
|
| Outpatient Clinics, Hospital | 2 | 2014 | 392 | 0.480 |
Why?
|
| Mental Recall | 3 | 2017 | 1205 | 0.470 |
Why?
|
| Follicular Fluid | 3 | 2023 | 87 | 0.460 |
Why?
|
| Puberty | 3 | 2022 | 489 | 0.440 |
Why?
|
| Women's Health | 4 | 2017 | 2034 | 0.440 |
Why?
|
| Parabens | 3 | 2023 | 108 | 0.430 |
Why?
|
| Isoflavones | 2 | 2015 | 139 | 0.430 |
Why?
|
| Endometrial Neoplasms | 1 | 2022 | 1351 | 0.420 |
Why?
|
| Risk | 18 | 2021 | 9679 | 0.420 |
Why?
|
| Hypertension | 7 | 2022 | 8455 | 0.420 |
Why?
|
| Multivariate Analysis | 16 | 2019 | 12242 | 0.410 |
Why?
|
| Coronary Disease | 3 | 2024 | 6078 | 0.410 |
Why?
|
| Dietary Fiber | 3 | 2022 | 760 | 0.410 |
Why?
|
| Lipogenesis | 1 | 2013 | 212 | 0.410 |
Why?
|
| Mercury | 3 | 2021 | 285 | 0.400 |
Why?
|
| Fatty Acids, Unsaturated | 4 | 2017 | 546 | 0.400 |
Why?
|
| Odds Ratio | 18 | 2022 | 9846 | 0.400 |
Why?
|
| Bisexuality | 4 | 2021 | 270 | 0.400 |
Why?
|
| Smoking | 9 | 2023 | 8969 | 0.390 |
Why?
|
| Insulin Resistance | 4 | 2021 | 3861 | 0.390 |
Why?
|
| Blood Glucose | 6 | 2021 | 6249 | 0.380 |
Why?
|
| Confidence Intervals | 6 | 2016 | 2970 | 0.380 |
Why?
|
| Citrus sinensis | 2 | 2020 | 16 | 0.370 |
Why?
|
| Adiponectin | 4 | 2021 | 1099 | 0.360 |
Why?
|
| Hormones | 1 | 2014 | 884 | 0.360 |
Why?
|
| Data Collection | 3 | 2020 | 3339 | 0.360 |
Why?
|
| Birth Order | 2 | 2023 | 95 | 0.360 |
Why?
|
| Testosterone | 5 | 2023 | 2401 | 0.360 |
Why?
|
| Research Design | 6 | 2023 | 5979 | 0.360 |
Why?
|
| Vehicle Emissions | 3 | 2019 | 665 | 0.350 |
Why?
|
| Oocyte Retrieval | 5 | 2020 | 161 | 0.350 |
Why?
|
| Embryo Transfer | 4 | 2020 | 511 | 0.340 |
Why?
|
| Embryo Implantation | 4 | 2021 | 272 | 0.340 |
Why?
|
| Alkanesulfonic Acids | 2 | 2022 | 180 | 0.340 |
Why?
|
| Lymphoma, Non-Hodgkin | 3 | 2022 | 1379 | 0.340 |
Why?
|
| Seasons | 3 | 2021 | 1492 | 0.330 |
Why?
|
| Massachusetts | 11 | 2021 | 8662 | 0.330 |
Why?
|
| DNA Fragmentation | 1 | 2009 | 242 | 0.330 |
Why?
|
| Depression, Postpartum | 2 | 2023 | 339 | 0.320 |
Why?
|
| Autistic Disorder | 3 | 2022 | 1174 | 0.320 |
Why?
|
| Cattle | 1 | 2014 | 3923 | 0.320 |
Why?
|
| New York | 3 | 2016 | 886 | 0.310 |
Why?
|
| Oleic Acid | 1 | 2008 | 85 | 0.310 |
Why?
|
| Birth Rate | 3 | 2019 | 170 | 0.310 |
Why?
|
| Michigan | 2 | 2018 | 350 | 0.300 |
Why?
|
| Texas | 2 | 2018 | 392 | 0.290 |
Why?
|
| Demography | 4 | 2023 | 1650 | 0.290 |
Why?
|
| Poultry | 2 | 2018 | 82 | 0.290 |
Why?
|
| Anxiety | 6 | 2023 | 4279 | 0.290 |
Why?
|
| Linoleic Acid | 1 | 2008 | 157 | 0.290 |
Why?
|
| Nutrition Surveys | 6 | 2021 | 1656 | 0.290 |
Why?
|
| Metabolome | 4 | 2023 | 881 | 0.280 |
Why?
|
| Embryo, Mammalian | 1 | 2012 | 1692 | 0.280 |
Why?
|
| Logistic Models | 11 | 2018 | 13403 | 0.280 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 2 | 2017 | 159 | 0.270 |
Why?
|
| Blood Pressure | 2 | 2022 | 8541 | 0.270 |
Why?
|
| Solanum tuberosum | 2 | 2016 | 37 | 0.270 |
Why?
|
| Patient Compliance | 4 | 2019 | 2680 | 0.270 |
Why?
|
| Vitamin D | 5 | 2019 | 3211 | 0.270 |
Why?
|
| Time Factors | 17 | 2021 | 40054 | 0.270 |
Why?
|
| Pregnancy Trimester, Second | 2 | 2018 | 732 | 0.260 |
Why?
|
| Spain | 4 | 2019 | 465 | 0.260 |
Why?
|
| Risk Assessment | 15 | 2020 | 23320 | 0.250 |
Why?
|
| Milk | 3 | 2021 | 449 | 0.250 |
Why?
|
| Epidemiologic Studies | 3 | 2017 | 676 | 0.250 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 2 | 2017 | 357 | 0.250 |
Why?
|
| Protective Clothing | 3 | 2020 | 102 | 0.240 |
Why?
|
| Fish Oils | 2 | 2020 | 469 | 0.240 |
Why?
|
| Depression | 9 | 2024 | 7733 | 0.240 |
Why?
|
| Reference Values | 4 | 2016 | 4982 | 0.240 |
Why?
|
| Luteinizing Hormone | 3 | 2021 | 864 | 0.230 |
Why?
|
| Motor Activity | 4 | 2018 | 2714 | 0.230 |
Why?
|
| Bariatric Surgery | 1 | 2013 | 940 | 0.230 |
Why?
|
| Lactation | 3 | 2022 | 412 | 0.230 |
Why?
|
| Premenopause | 3 | 2015 | 1033 | 0.230 |
Why?
|
| Reproducibility of Results | 7 | 2019 | 19862 | 0.220 |
Why?
|
| Ovulation Induction | 4 | 2023 | 274 | 0.220 |
Why?
|
| Aged | 30 | 2024 | 162944 | 0.220 |
Why?
|
| Hair | 2 | 2017 | 483 | 0.220 |
Why?
|
| Oocytes | 4 | 2023 | 1186 | 0.220 |
Why?
|
| Azoospermia | 2 | 2012 | 27 | 0.210 |
Why?
|
| Oligospermia | 2 | 2012 | 59 | 0.210 |
Why?
|
| Nursing Staff, Hospital | 2 | 2017 | 346 | 0.210 |
Why?
|
| Treatment Outcome | 21 | 2022 | 62966 | 0.210 |
Why?
|
| School Health Services | 1 | 2005 | 375 | 0.210 |
Why?
|
| Diet, Carbohydrate-Restricted | 2 | 2015 | 257 | 0.210 |
Why?
|
| Azocines | 1 | 2021 | 18 | 0.210 |
Why?
|
| Waist-Hip Ratio | 2 | 2020 | 517 | 0.210 |
Why?
|
| Case-Control Studies | 11 | 2022 | 21719 | 0.210 |
Why?
|
| Antineoplastic Agents | 3 | 2020 | 13655 | 0.210 |
Why?
|
| Food | 2 | 2017 | 769 | 0.210 |
Why?
|
| Pandemics | 7 | 2023 | 8328 | 0.200 |
Why?
|
| Family Characteristics | 3 | 2016 | 999 | 0.200 |
Why?
|
| Reproductive Techniques | 1 | 2021 | 42 | 0.200 |
Why?
|
| Pregnancy, Unplanned | 2 | 2019 | 95 | 0.200 |
Why?
|
| Chromatography, Gas | 2 | 2012 | 156 | 0.200 |
Why?
|
| Child, Preschool | 11 | 2023 | 40955 | 0.200 |
Why?
|
| Food, Organic | 2 | 2018 | 34 | 0.190 |
Why?
|
| Boston | 9 | 2023 | 9305 | 0.190 |
Why?
|
| Prenatal Care | 2 | 2018 | 1088 | 0.190 |
Why?
|
| Academic Medical Centers | 5 | 2017 | 2749 | 0.180 |
Why?
|
| Nitrogen Dioxide | 2 | 2020 | 490 | 0.180 |
Why?
|
| Gonadal Hormones | 1 | 2020 | 29 | 0.180 |
Why?
|
| Calcium, Dietary | 2 | 2013 | 527 | 0.180 |
Why?
|
| Ownership | 1 | 2022 | 331 | 0.180 |
Why?
|
| Singapore | 1 | 2021 | 295 | 0.180 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2021 | 271 | 0.180 |
Why?
|
| Trihalomethanes | 1 | 2019 | 23 | 0.180 |
Why?
|
| Magnesium | 2 | 2013 | 813 | 0.180 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2024 | 369 | 0.180 |
Why?
|
| Amenorrhea | 1 | 2023 | 485 | 0.170 |
Why?
|
| North America | 1 | 2023 | 1249 | 0.170 |
Why?
|
| Obesity, Abdominal | 2 | 2021 | 361 | 0.170 |
Why?
|
| Genomic Imprinting | 1 | 2021 | 331 | 0.170 |
Why?
|
| Hand Strength | 1 | 2022 | 444 | 0.170 |
Why?
|
| Benzophenones | 1 | 2019 | 57 | 0.170 |
Why?
|
| Erythrocyte Membrane | 1 | 2020 | 442 | 0.170 |
Why?
|
| Sex Hormone-Binding Globulin | 4 | 2020 | 548 | 0.170 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 9941 | 0.170 |
Why?
|
| Health Surveys | 3 | 2021 | 4030 | 0.170 |
Why?
|
| Vaccination | 2 | 2022 | 3256 | 0.170 |
Why?
|
| Sex Offenses | 1 | 2023 | 352 | 0.170 |
Why?
|
| Food Handling | 2 | 2017 | 145 | 0.160 |
Why?
|
| Shellfish | 2 | 2018 | 38 | 0.160 |
Why?
|
| Breast Feeding | 6 | 2024 | 1339 | 0.160 |
Why?
|
| Sunscreening Agents | 1 | 2019 | 132 | 0.160 |
Why?
|
| Estradiol | 6 | 2023 | 2021 | 0.160 |
Why?
|
| Sterilization, Tubal | 1 | 2018 | 87 | 0.160 |
Why?
|
| Education, Continuing | 1 | 2019 | 112 | 0.160 |
Why?
|
| Iron | 1 | 2006 | 1773 | 0.160 |
Why?
|
| Carbohydrates | 1 | 2020 | 391 | 0.160 |
Why?
|
| Animals | 20 | 2024 | 168561 | 0.160 |
Why?
|
| Interviews as Topic | 2 | 2018 | 2536 | 0.150 |
Why?
|
| Parents | 2 | 2023 | 3387 | 0.150 |
Why?
|
| Progesterone | 3 | 2020 | 773 | 0.150 |
Why?
|
| Severity of Illness Index | 5 | 2021 | 15530 | 0.150 |
Why?
|
| Nursing | 1 | 2017 | 40 | 0.150 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 253 | 0.150 |
Why?
|
| National Cancer Institute (U.S.) | 2 | 2016 | 281 | 0.150 |
Why?
|
| Vitamin D Deficiency | 2 | 2017 | 1331 | 0.150 |
Why?
|
| Spermatogenesis | 2 | 2019 | 262 | 0.150 |
Why?
|
| Automobiles | 1 | 2018 | 116 | 0.150 |
Why?
|
| Cell Shape | 2 | 2015 | 375 | 0.150 |
Why?
|
| Insemination, Artificial | 2 | 2014 | 98 | 0.150 |
Why?
|
| Sarcopenia | 1 | 2022 | 368 | 0.150 |
Why?
|
| Leiomyoma | 1 | 2022 | 728 | 0.150 |
Why?
|
| Contraception Behavior | 1 | 2019 | 184 | 0.150 |
Why?
|
| Hyperlipidemias | 1 | 2022 | 786 | 0.150 |
Why?
|
| Intrauterine Devices | 1 | 2018 | 122 | 0.150 |
Why?
|
| Ozone | 1 | 2020 | 469 | 0.150 |
Why?
|
| Nutrition Policy | 1 | 2021 | 488 | 0.150 |
Why?
|
| Family Planning Services | 1 | 2019 | 258 | 0.150 |
Why?
|
| Habits | 1 | 2017 | 137 | 0.150 |
Why?
|
| Sperm-Ovum Interactions | 1 | 2016 | 24 | 0.150 |
Why?
|
| Interleukin-6 | 2 | 2017 | 3199 | 0.140 |
Why?
|
| Reproductive Behavior | 1 | 2016 | 29 | 0.140 |
Why?
|
| Sulfones | 1 | 2019 | 437 | 0.140 |
Why?
|
| Folic Acid Deficiency | 1 | 2017 | 115 | 0.140 |
Why?
|
| Men's Health | 1 | 2017 | 73 | 0.140 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 2016 | 39 | 0.140 |
Why?
|
| Anthropometry | 1 | 2021 | 1350 | 0.140 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2018 | 370 | 0.140 |
Why?
|
| American Heart Association | 1 | 2021 | 1055 | 0.140 |
Why?
|
| Particulate Matter | 4 | 2023 | 2523 | 0.140 |
Why?
|
| Inflammation | 5 | 2021 | 10578 | 0.140 |
Why?
|
| Ovary | 1 | 2021 | 981 | 0.140 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2019 | 253 | 0.140 |
Why?
|
| Dyslipidemias | 1 | 2024 | 848 | 0.140 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2018 | 455 | 0.140 |
Why?
|
| Survival Rate | 3 | 2015 | 12773 | 0.140 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2022 | 1185 | 0.140 |
Why?
|
| Glycemic Index | 3 | 2022 | 395 | 0.140 |
Why?
|
| Stress, Psychological | 4 | 2022 | 4229 | 0.140 |
Why?
|
| Water Pollutants, Chemical | 1 | 2019 | 311 | 0.140 |
Why?
|
| DNA Methylation | 2 | 2021 | 4282 | 0.140 |
Why?
|
| Phytoestrogens | 1 | 2016 | 61 | 0.140 |
Why?
|
| Carotid Artery Diseases | 1 | 2022 | 882 | 0.130 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2017 | 227 | 0.130 |
Why?
|
| Calcifediol | 1 | 2016 | 166 | 0.130 |
Why?
|
| Contraception | 1 | 2019 | 356 | 0.130 |
Why?
|
| Dietary Sucrose | 1 | 2017 | 247 | 0.130 |
Why?
|
| Beer | 1 | 2015 | 127 | 0.130 |
Why?
|
| Phlebotomy | 1 | 2016 | 142 | 0.130 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2015 | 54 | 0.130 |
Why?
|
| Ubiquinone | 1 | 2016 | 188 | 0.130 |
Why?
|
| Immunoenzyme Techniques | 1 | 2018 | 1799 | 0.130 |
Why?
|
| Iron, Dietary | 1 | 2016 | 141 | 0.130 |
Why?
|
| C-Reactive Protein | 2 | 2017 | 3766 | 0.130 |
Why?
|
| Wine | 1 | 2015 | 165 | 0.130 |
Why?
|
| Tea | 1 | 2016 | 275 | 0.130 |
Why?
|
| Androstanes | 1 | 2014 | 21 | 0.120 |
Why?
|
| Temperature | 1 | 2021 | 2207 | 0.120 |
Why?
|
| Women, Working | 1 | 2015 | 87 | 0.120 |
Why?
|
| Blastocyst | 1 | 2017 | 424 | 0.120 |
Why?
|
| Diet, Fat-Restricted | 2 | 2014 | 317 | 0.120 |
Why?
|
| Pregnancy Trimester, First | 1 | 2018 | 851 | 0.120 |
Why?
|
| Health Behavior | 4 | 2017 | 2630 | 0.120 |
Why?
|
| Triglycerides | 1 | 2022 | 2450 | 0.120 |
Why?
|
| Regression Analysis | 5 | 2017 | 6452 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2019 | 987 | 0.120 |
Why?
|
| Fertility Agents, Female | 1 | 2014 | 99 | 0.120 |
Why?
|
| Growth | 1 | 2016 | 376 | 0.120 |
Why?
|
| Iron Overload | 1 | 2016 | 243 | 0.120 |
Why?
|
| Chi-Square Distribution | 2 | 2017 | 3510 | 0.120 |
Why?
|
| Abortion, Induced | 1 | 2019 | 458 | 0.120 |
Why?
|
| Fibroblast Growth Factors | 1 | 2019 | 879 | 0.120 |
Why?
|
| Adolescent Development | 1 | 2017 | 277 | 0.120 |
Why?
|
| Government Programs | 1 | 2016 | 275 | 0.120 |
Why?
|
| Occupational Health | 2 | 2017 | 809 | 0.110 |
Why?
|
| Cholesterol, Dietary | 1 | 2014 | 231 | 0.110 |
Why?
|
| Cheese | 1 | 2013 | 38 | 0.110 |
Why?
|
| Congenital Abnormalities | 1 | 2018 | 707 | 0.110 |
Why?
|
| Aged, 80 and over | 9 | 2021 | 57683 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2014 | 10943 | 0.110 |
Why?
|
| Thyroid Gland | 1 | 2020 | 1172 | 0.110 |
Why?
|
| Bayes Theorem | 4 | 2023 | 2303 | 0.110 |
Why?
|
| Housing | 1 | 2018 | 663 | 0.110 |
Why?
|
| Fatty Liver | 1 | 2019 | 728 | 0.110 |
Why?
|
| Sleep | 3 | 2024 | 4604 | 0.110 |
Why?
|
| Insulin | 4 | 2021 | 6575 | 0.110 |
Why?
|
| Cholesterol | 1 | 2022 | 2895 | 0.110 |
Why?
|
| Retrospective Studies | 9 | 2022 | 77098 | 0.110 |
Why?
|
| Maternal Exposure | 1 | 2019 | 961 | 0.110 |
Why?
|
| Metabolic Diseases | 1 | 2019 | 657 | 0.110 |
Why?
|
| Hot Temperature | 1 | 2018 | 1355 | 0.110 |
Why?
|
| Vitamin B 12 | 1 | 2015 | 527 | 0.110 |
Why?
|
| Risk Adjustment | 1 | 2016 | 594 | 0.110 |
Why?
|
| Oxidative Stress | 2 | 2020 | 3081 | 0.110 |
Why?
|
| Central Nervous System Stimulants | 2 | 2018 | 1148 | 0.100 |
Why?
|
| Research | 2 | 2023 | 1999 | 0.100 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3130 | 0.100 |
Why?
|
| Energy Intake | 4 | 2022 | 2147 | 0.100 |
Why?
|
| Circadian Rhythm | 1 | 2024 | 2623 | 0.100 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3236 | 0.100 |
Why?
|
| Leptin | 1 | 2019 | 1593 | 0.100 |
Why?
|
| Gestational Age | 2 | 2019 | 3490 | 0.100 |
Why?
|
| Meta-Analysis as Topic | 1 | 2016 | 1342 | 0.100 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2015 | 484 | 0.100 |
Why?
|
| Leisure Activities | 1 | 2013 | 311 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2020 | 15494 | 0.100 |
Why?
|
| Diet, Reducing | 1 | 2014 | 461 | 0.090 |
Why?
|
| Androgens | 1 | 2018 | 1271 | 0.090 |
Why?
|
| Colombia | 3 | 2009 | 259 | 0.090 |
Why?
|
| Loneliness | 2 | 2022 | 184 | 0.090 |
Why?
|
| Heart | 1 | 2024 | 4462 | 0.090 |
Why?
|
| Health Status | 1 | 2023 | 4030 | 0.090 |
Why?
|
| Health Personnel | 2 | 2021 | 3210 | 0.090 |
Why?
|
| Gloves, Protective | 2 | 2020 | 22 | 0.090 |
Why?
|
| Asthma | 2 | 2021 | 5955 | 0.090 |
Why?
|
| Glucose Intolerance | 1 | 2014 | 577 | 0.090 |
Why?
|
| Prevalence | 4 | 2020 | 15194 | 0.090 |
Why?
|
| Mortality | 1 | 2021 | 2857 | 0.090 |
Why?
|
| Skinfold Thickness | 2 | 2009 | 162 | 0.090 |
Why?
|
| Physical Examination | 1 | 2016 | 1239 | 0.090 |
Why?
|
| Osmolar Concentration | 1 | 2010 | 683 | 0.090 |
Why?
|
| Child Nutrition Sciences | 1 | 2009 | 23 | 0.090 |
Why?
|
| Hypothyroidism | 1 | 2014 | 659 | 0.090 |
Why?
|
| Disease Progression | 5 | 2019 | 13256 | 0.090 |
Why?
|
| Metabolomics | 1 | 2018 | 1467 | 0.090 |
Why?
|
| Age Distribution | 3 | 2017 | 2900 | 0.090 |
Why?
|
| Guideline Adherence | 2 | 2016 | 2266 | 0.080 |
Why?
|
| Recurrence | 1 | 2021 | 8333 | 0.080 |
Why?
|
| Ethanol | 1 | 2015 | 1337 | 0.080 |
Why?
|
| Quantitative Trait Loci | 1 | 2016 | 2015 | 0.080 |
Why?
|
| Republic of Korea | 2 | 2023 | 538 | 0.080 |
Why?
|
| Ohio | 1 | 2009 | 337 | 0.080 |
Why?
|
| Contraceptive Agents | 2 | 2020 | 150 | 0.080 |
Why?
|
| Heart Diseases | 1 | 2021 | 2789 | 0.080 |
Why?
|
| Papillomavirus Infections | 1 | 2020 | 1585 | 0.080 |
Why?
|
| Specimen Handling | 1 | 2013 | 692 | 0.080 |
Why?
|
| Nutritive Value | 2 | 2021 | 339 | 0.080 |
Why?
|
| Sex Factors | 4 | 2019 | 10392 | 0.080 |
Why?
|
| Inhibins | 2 | 2020 | 211 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2020 | 3915 | 0.080 |
Why?
|
| Ambulatory Care Facilities | 2 | 2017 | 932 | 0.080 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2020 | 2011 | 0.080 |
Why?
|
| Socioeconomic Factors | 4 | 2021 | 7770 | 0.080 |
Why?
|
| Age Factors | 5 | 2017 | 18355 | 0.080 |
Why?
|
| Medical Records | 2 | 2017 | 1413 | 0.070 |
Why?
|
| Glioma | 1 | 2022 | 3388 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2022 | 17400 | 0.070 |
Why?
|
| Interdisciplinary Communication | 1 | 2013 | 950 | 0.070 |
Why?
|
| Postpartum Period | 2 | 2023 | 1078 | 0.070 |
Why?
|
| Video Games | 1 | 2009 | 184 | 0.070 |
Why?
|
| Predictive Value of Tests | 3 | 2017 | 15056 | 0.070 |
Why?
|
| Lipids | 3 | 2024 | 3302 | 0.070 |
Why?
|
| Postmenopause | 1 | 2015 | 2461 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 4929 | 0.070 |
Why?
|
| Bacteria | 1 | 2017 | 2102 | 0.070 |
Why?
|
| Homicide | 1 | 2009 | 287 | 0.070 |
Why?
|
| Atherosclerosis | 1 | 2022 | 3428 | 0.070 |
Why?
|
| Biomedical Research | 2 | 2019 | 3306 | 0.070 |
Why?
|
| Health Promotion | 1 | 2018 | 2194 | 0.070 |
Why?
|
| Software | 1 | 2020 | 4434 | 0.070 |
Why?
|
| Administration, Oral | 1 | 2013 | 3913 | 0.070 |
Why?
|
| Energy Metabolism | 2 | 2016 | 2896 | 0.070 |
Why?
|
| Food Supply | 1 | 2011 | 517 | 0.070 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2007 | 226 | 0.070 |
Why?
|
| Maternal Age | 2 | 2020 | 802 | 0.070 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 3639 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2014 | 6365 | 0.060 |
Why?
|
| Body Height | 2 | 2016 | 1574 | 0.060 |
Why?
|
| Physician-Patient Relations | 1 | 2018 | 3215 | 0.060 |
Why?
|
| Survival Analysis | 2 | 2015 | 10248 | 0.060 |
Why?
|
| Eicosapentaenoic Acid | 2 | 2022 | 582 | 0.060 |
Why?
|
| Genome-Wide Association Study | 3 | 2020 | 12220 | 0.060 |
Why?
|
| Prognosis | 5 | 2019 | 29010 | 0.060 |
Why?
|
| Thyrotropin | 2 | 2020 | 850 | 0.060 |
Why?
|
| Comorbidity | 4 | 2022 | 10372 | 0.060 |
Why?
|
| Gonadotropins | 2 | 2015 | 241 | 0.060 |
Why?
|
| Agriculture | 1 | 2005 | 187 | 0.060 |
Why?
|
| Social Environment | 1 | 2009 | 1023 | 0.060 |
Why?
|
| PPAR gamma | 1 | 2007 | 493 | 0.060 |
Why?
|
| China | 2 | 2019 | 2246 | 0.060 |
Why?
|
| Combined Modality Therapy | 2 | 2014 | 8621 | 0.060 |
Why?
|
| Infant | 6 | 2020 | 35070 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 8425 | 0.060 |
Why?
|
| Soil | 1 | 2023 | 106 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2020 | 8297 | 0.060 |
Why?
|
| Placebos | 1 | 2007 | 1677 | 0.050 |
Why?
|
| Violence | 1 | 2009 | 908 | 0.050 |
Why?
|
| Telemedicine | 1 | 2020 | 2853 | 0.050 |
Why?
|
| Environmental Monitoring | 2 | 2019 | 1413 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2007 | 1961 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2023 | 11690 | 0.050 |
Why?
|
| Biological Clocks | 1 | 2024 | 322 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 2 | 2009 | 2714 | 0.050 |
Why?
|
| Stroke | 1 | 2024 | 9963 | 0.050 |
Why?
|
| C-Peptide | 1 | 2022 | 416 | 0.050 |
Why?
|
| France | 2 | 2012 | 517 | 0.050 |
Why?
|
| Missouri | 1 | 2020 | 116 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2010 | 5062 | 0.050 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 11001 | 0.050 |
Why?
|
| Fast Foods | 1 | 2022 | 197 | 0.050 |
Why?
|
| Plants | 1 | 2021 | 314 | 0.050 |
Why?
|
| Glutens | 1 | 2022 | 230 | 0.050 |
Why?
|
| Algorithms | 1 | 2020 | 13853 | 0.040 |
Why?
|
| Latin America | 1 | 2021 | 381 | 0.040 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2019 | 73 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 7276 | 0.040 |
Why?
|
| Dogs | 1 | 2024 | 3910 | 0.040 |
Why?
|
| Prostate | 1 | 2007 | 1764 | 0.040 |
Why?
|
| Reproductive Health Services | 1 | 2019 | 80 | 0.040 |
Why?
|
| Ovarian Neoplasms | 1 | 2015 | 4823 | 0.040 |
Why?
|
| Dental Health Surveys | 1 | 2018 | 43 | 0.040 |
Why?
|
| Iodide Peroxidase | 1 | 2020 | 293 | 0.040 |
Why?
|
| Women | 1 | 2020 | 230 | 0.040 |
Why?
|
| Sweden | 1 | 2021 | 1343 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 14720 | 0.040 |
Why?
|
| Carnitine | 1 | 2019 | 239 | 0.040 |
Why?
|
| Pregnancy in Adolescence | 1 | 2019 | 157 | 0.040 |
Why?
|
| Selection, Genetic | 1 | 2023 | 914 | 0.040 |
Why?
|
| Aspartate Aminotransferases | 1 | 2019 | 418 | 0.040 |
Why?
|
| Thyroid Hormones | 1 | 2020 | 390 | 0.040 |
Why?
|
| Plasma | 1 | 2021 | 575 | 0.040 |
Why?
|
| Cell Count | 1 | 2021 | 1831 | 0.040 |
Why?
|
| New England | 1 | 2020 | 1021 | 0.040 |
Why?
|
| Climate | 1 | 2018 | 147 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2020 | 939 | 0.040 |
Why?
|
| Age of Onset | 2 | 2017 | 3266 | 0.040 |
Why?
|
| Vaginal Smears | 1 | 2020 | 511 | 0.040 |
Why?
|
| Respiratory Protective Devices | 1 | 2017 | 46 | 0.040 |
Why?
|
| Eggs | 1 | 2018 | 184 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2009 | 3278 | 0.040 |
Why?
|
| Alanine Transaminase | 1 | 2019 | 592 | 0.040 |
Why?
|
| Walking | 1 | 2024 | 1177 | 0.040 |
Why?
|
| Adolescent Nutritional Physiological Phenomena | 1 | 2016 | 63 | 0.030 |
Why?
|
| Endometrium | 1 | 2019 | 424 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 707 | 0.030 |
Why?
|
| Public Health | 2 | 2020 | 2594 | 0.030 |
Why?
|
| Ultrasonography | 2 | 2021 | 5978 | 0.030 |
Why?
|
| Immunoassay | 1 | 2019 | 752 | 0.030 |
Why?
|
| Geography | 1 | 2018 | 669 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 2017 | 512 | 0.030 |
Why?
|
| Adult Children | 1 | 2016 | 99 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2023 | 20774 | 0.030 |
Why?
|
| Pectinidae | 1 | 2015 | 5 | 0.030 |
Why?
|
| Docosahexaenoic Acids | 1 | 2022 | 875 | 0.030 |
Why?
|
| Canada | 1 | 2021 | 2061 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2019 | 977 | 0.030 |
Why?
|
| Fetal Macrosomia | 1 | 2016 | 124 | 0.030 |
Why?
|
| Organophosphorus Compounds | 1 | 2016 | 215 | 0.030 |
Why?
|
| Research Support as Topic | 1 | 2019 | 704 | 0.030 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2016 | 128 | 0.030 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 740 | 0.030 |
Why?
|
| Fetal Blood | 1 | 2021 | 1317 | 0.030 |
Why?
|
| Stearic Acids | 1 | 2014 | 53 | 0.030 |
Why?
|
| Physicians | 1 | 2012 | 4554 | 0.030 |
Why?
|
| Mother-Child Relations | 1 | 2018 | 481 | 0.030 |
Why?
|
| Clomiphene | 1 | 2014 | 72 | 0.030 |
Why?
|
| CpG Islands | 1 | 2018 | 1170 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 2030 | 0.030 |
Why?
|
| Heme | 1 | 2016 | 307 | 0.030 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2019 | 963 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2019 | 1905 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2016 | 571 | 0.030 |
Why?
|
| Internal-External Control | 1 | 2015 | 363 | 0.030 |
Why?
|
| Vital Capacity | 1 | 2016 | 922 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2007 | 12017 | 0.030 |
Why?
|
| Family Health | 1 | 2018 | 1282 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2019 | 1157 | 0.030 |
Why?
|
| Drug Utilization Review | 1 | 2014 | 245 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2022 | 3744 | 0.030 |
Why?
|
| Endpoint Determination | 1 | 2015 | 600 | 0.030 |
Why?
|
| Curriculum | 1 | 2005 | 3589 | 0.030 |
Why?
|
| Child Behavior | 1 | 2018 | 838 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2020 | 1348 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2017 | 2295 | 0.030 |
Why?
|
| Minority Groups | 1 | 2019 | 1215 | 0.030 |
Why?
|
| Organ Size | 1 | 2017 | 2253 | 0.030 |
Why?
|
| Particle Size | 1 | 2016 | 1640 | 0.020 |
Why?
|
| Financing, Personal | 1 | 2014 | 308 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 2016 | 1364 | 0.020 |
Why?
|
| Forced Expiratory Volume | 1 | 2016 | 1741 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2014 | 1150 | 0.020 |
Why?
|
| Workload | 1 | 2017 | 849 | 0.020 |
Why?
|
| Employment | 1 | 2017 | 1124 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 2016 | 1460 | 0.020 |
Why?
|
| Universities | 1 | 2015 | 953 | 0.020 |
Why?
|
| Epidemiologic Research Design | 1 | 2013 | 367 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2013 | 780 | 0.020 |
Why?
|
| Sexual Development | 1 | 2009 | 34 | 0.020 |
Why?
|
| Gastrointestinal Diseases | 1 | 2017 | 1167 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2008 | 6754 | 0.020 |
Why?
|
| Economics | 1 | 2009 | 146 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2018 | 2049 | 0.020 |
Why?
|
| Adolescent Behavior | 1 | 2016 | 1150 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2019 | 3584 | 0.020 |
Why?
|
| Alleles | 1 | 2018 | 6931 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 9735 | 0.020 |
Why?
|
| Mexico | 1 | 2009 | 688 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2014 | 2451 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 1503 | 0.020 |
Why?
|
| Income | 1 | 2014 | 1904 | 0.020 |
Why?
|
| Hospitals | 1 | 2018 | 3937 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2021 | 5133 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2019 | 6540 | 0.010 |
Why?
|
| Aging | 1 | 2023 | 8626 | 0.010 |
Why?
|
| Video Recording | 1 | 2009 | 944 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2019 | 10472 | 0.010 |
Why?
|
| Genotype | 1 | 2018 | 12946 | 0.010 |
Why?
|
| Models, Biological | 1 | 2020 | 9581 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 16665 | 0.010 |
Why?
|
| Insurance Coverage | 1 | 2014 | 1895 | 0.010 |
Why?
|
| Hospitalization | 1 | 2022 | 10232 | 0.010 |
Why?
|
| Phenotype | 1 | 2016 | 16331 | 0.010 |
Why?
|
| Patient Selection | 1 | 2010 | 4214 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 7901 | 0.010 |
Why?
|